Evaluation of Antiinflammatory Activity of 4'-О-Methylhonokiol Derivatives in a Neuroinflammation Model


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The synthesis of two derivatives of lignan 4'-O-methylhonokiol (MH), i.e., 4'-methoxy-5-propyl-1,1'-biphenyl-2-ol (III) and 4'-(2-fluoroethoxy)-2-hydroxy-5-propyl-1,1'-biphenyl (VI) has been described. Derivative (VI) demonstrates the highest anti-inflammatory activity in the lipopolysaccharide-induced (LPS-induced) neuroinflammation mouse model. Its effect on the morphological changes in the brain is comparable to that of celecoxib, a well-known nonsteroid anti-inflammatory drug and a selective inhibitor of cyclooxygenase-2 (COX 2).

About the authors

K. V. Sivak

Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation

Email: gomzina@ihb.spb.ru
Russian Federation, St. Petersburg, 197376

K. I. Stosman

Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation

Email: gomzina@ihb.spb.ru
Russian Federation, St. Petersburg, 197376

A. A. Muzhikyan

Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation

Email: gomzina@ihb.spb.ru
Russian Federation, St. Petersburg, 197376

A. G. Alexandrov

Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation

Email: gomzina@ihb.spb.ru
Russian Federation, St. Petersburg, 197376

N. B. Viktorov

St. Petersburg State Technological Institute (Technical University)

Email: gomzina@ihb.spb.ru
Russian Federation, St. Petersburg, 190013

D. D. Vaulina

Bechterev Institute of Human Brain, Russian Academy of Science

Email: gomzina@ihb.spb.ru
Russian Federation, St. Petersburg, 197376

N. A. Gomzina

Bechterev Institute of Human Brain, Russian Academy of Science

Author for correspondence.
Email: gomzina@ihb.spb.ru
Russian Federation, St. Petersburg, 197376


Copyright (c) 2019 Pleiades Publishing, Ltd.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies